AI healthcare platform Medicus raises $3.1m funding

AI healthcare platform Medicus raises $3.1m funding
Medicus is helping to make healthcare easier to understand for users, while empowering healthcare professionals.
Published: 4 February 2019 - 7:50 a.m.
By: Mark Sutton

AI medical reporting platform Medicus AI GmbH has announced the completion of the first tranche of its Series A funding round at €2.75 million ($3.1m).

The AI platform, which was founded in Dubai in 2015, interprets medical reports and data for doctors and patients.

The funding round will be used to fund global expansion, and to develop the Medicus diagnostic lab and insurance products, across core markets and in new languages.

The company said it aims to closed the second tranche of over €2.25 million ($2.57m) over the coming months.

Medicus is an AI-based platform that explains and interprets medical reports and health data, turning numbers into meaningful insights. Medicus works with diagnostic labs to deliver smart features and insights to both doctors, in terms of smart testing and diagnosis support, and to patients in the form of visual and interactive reports, powering continuous healthcare and coaching across all digital platforms.

"At Medicus, we believe that healthcare is in dire need of a user-experience overhaul and that people these days are used to experiencing things in a much simpler and clear fashion, yet healthcare is still complex and impenetrable. We believe that this augmentation can unlock massive value that reverberates across the whole healthcare system," said Dr Baher al Hakim, CEO, Medicus.

The diagnostic lab space, which makes up Medicus' current core client base, generates an estimated 20 billion reports annually worldwide. However, the industry operates in highly consolidated markets and struggle to differentiate themselves, maintain growth and introduce future-proof business models.

"Our proposition to diagnostic labs is simple. We empower labs to deliver defensible value-add services that augment their existing products. We believe that lab directors only have a few years to decide how to react to the impending waves of innovation incrementally disrupting their industry. The market is struggling under increased commoditization, lowering margins and tightening regulations. This is where Medicus comes in; through innovation we help labs build an attractive and integral service offering," explained Dr Baher.

Today Medicus is focused on scalable distribution strategy in existing and new markets. In late 2018, Medicus signed a market access cooperation with Roche Diagnostics, which will amplify its global reach. Medicus is also currently in talks with a number of other distributors in countries spanning the globe.

"Medicus is working towards transforming the healthcare sector, simplifying the relations between healthcare providers and patients, and leading to better health outcomes," concluded Dr Baher. "Our growing global knowledge and partnerships will help us achieve these outcomes."

Click here to add your comment

Please add your comment below
Your email address will not be published